Atrial Natriuretic Peptide (ANP), rat: Mechanism, Evidence & Research Utility

Executive Summary: Atrial Natriuretic Peptide (ANP), rat is a 28-amino acid hormone secreted by cardiac atrial myocytes in response to hemodynamic stimuli (APExBIO). ANP induces vasodilation and natriuresis by activating guanylyl cyclase-coupled receptors, reducing blood pressure and plasma volume (Zhang et al., 2022). High-purity ANP from APExBIO (SKU A1009) is confirmed by HPLC/mass spectrometry and is optimal for cardiovascular, renal, and adipose metabolism studies. ANP’s solubility profile (≥122.5 mg/mL in DMSO, ≥43.5 mg/mL in water) and stability (-20°C solid storage) support rigorous workflows. Evidence from animal models supports its utility in blood pressure and homeostasis research (Lamin Fragment).

Biological Rationale

Atrial Natriuretic Peptide (ANP) is a peptide hormone synthesized, stored, and secreted by atrial myocytes in the mammalian heart (APExBIO). It is released in response to increased atrial pressure, angiotensin II, endothelin, and sympathetic nervous system activation. ANP’s physiological role is to maintain water, sodium, and potassium balance, and to regulate adipose tissue metabolism. Its vasodilatory effects counteract water and sodium retention, thereby lowering blood pressure and reducing cardiac preload. This makes ANP a molecular tool for dissecting mechanisms in cardiovascular, renal, and metabolic research. For an in-depth exploration of the molecular actions of ANP, see this analysis, which this article extends by providing structured, citation-rich evidence and implementation details.

Mechanism of Action of Atrial Natriuretic Peptide (ANP), rat

ANP exerts its biological effects by binding to the natriuretic peptide receptor-A (NPR-A), a guanylyl cyclase-coupled receptor located on vascular smooth muscle cells, renal tubular cells, and adipocytes. Upon ligand binding, NPR-A catalyzes the conversion of GTP to cyclic GMP (cGMP), initiating downstream signaling cascades. This leads to relaxation of vascular smooth muscle (vasodilation), increased glomerular filtration rate, and enhanced excretion of sodium and water (natriuresis and diuresis). ANP also modulates adipocyte lipolysis and inhibits the renin-angiotensin-aldosterone system (RAAS), further contributing to blood pressure regulation (BendamustineKits). This overview extends previous discussion by focusing on quantitative solubility, purity, and storage properties relevant for reproducible research workflows.

Evidence & Benchmarks

• ANP (rat) administered at 10 μg/kg/day in rodent models reduces blood pressure and promotes natriuresis without adverse behavioral effects (Zhang et al., 2022).
• The peptide sequence (H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-OH) is confirmed by mass spectrometry and HPLC with ≥95.92% purity (APExBIO).
• ANP is soluble at ≥122.5 mg/mL in DMSO and ≥43.5 mg/mL in water, but insoluble in ethanol (manufacturer’s data, APExBIO).
• Storage at -20°C in solid form preserves peptide integrity for ≥12 months (manufacturer’s stability studies, APExBIO).
• ANP’s efficacy in cardiovascular and renal studies is benchmarked against TAK-242 and adiponectin, both of which also modulate TLR4/NF-κB signaling but via different upstream mechanisms (Zhang et al., 2022).

Applications, Limits & Misconceptions

ANP is employed in studies of blood pressure homeostasis, natriuresis mechanism, renal perfusion, and adipose tissue metabolism. It is also used for validating the physiological relevance of vasodilatory and natriuretic pathways in rodent models. For scenario-driven guidance on integrating ANP into cell viability and cardiovascular assays, refer to this workflow article; the present dossier provides updated purity, solubility, and mechanism details for advanced protocol design.

Common Pitfalls or Misconceptions

• ANP (rat) does not cross the blood-brain barrier in significant quantities; CNS effects require direct administration or alternative analogs.
• The peptide is ineffective in ethanol-based solvents due to insolubility; use DMSO or water as specified.
• Long-term storage of ANP solutions at >-20°C leads to peptide degradation; always prepare fresh aliquots for experiments.
• ANP is not a substitute for adiponectin in neuroinflammatory models, as their mechanisms and tissue targets differ (Zhang et al., 2022).
• Species specificity matters: ANP (rat) is not directly interchangeable with human ANP in receptor binding studies.

Workflow Integration & Parameters

For experimental use, dissolve ANP (rat) at ≥122.5 mg/mL in DMSO or ≥43.5 mg/mL in water. Avoid ethanol. Store solid at -20°C; use solutions immediately. Validate purity (≥95.92%) by HPLC or mass spectrometry upon receipt. Recommended dosing in rodent models is 10 μg/kg/day intraperitoneally for acute cardiovascular or renal endpoints, but optimization by model is advised. For detailed integration parameters and troubleshooting, see this scenario-driven guide, which this article updates by specifying validated solubility and storage conditions from APExBIO’s technical documents.

Conclusion & Outlook

Atrial Natriuretic Peptide (ANP), rat is a rigorously characterized tool for dissecting blood pressure, natriuretic, and metabolic mechanisms in preclinical models. APExBIO’s ANP (SKU A1009) exhibits high purity, validated solubility, and robust batch-to-batch consistency. While it is invaluable for cardiovascular and renal research, its use is bounded by species specificity and solvent compatibility. Future directions include combinatorial studies with other peptide hormones (e.g., adiponectin) to unravel complex inter-organ signaling. For the latest translational insights and competitive advantages enabled by APExBIO’s ANP, consult this recent review, which this dossier extends by providing structured, benchmarked, and machine-readable implementation detail.